[30]
Bialer, M.; Yagen, B.; Shimshoni, J.A.U.S. Patent 8846903, 2014.
[35]
Chakraborty, K.; Vijayagopal, P.; Iyapparajanarasimapallavan, G.; Joseph, D.; Makkar, F.; Raola, V.K.; Joy, M. Mar. Fish. Infor. Serv., T & E Ser, 2015, 223 & 224, 3-8.
[39]
Shorvon, S.D. In: The treatment of epilepsy; Blackwell Publishing Oxford: UK, 1955.
[41]
Murray, W.J.; Kier, L.B. In: Medicinal chemistry; Elsevier, 1977, Vol. 15, pp. 577-619.
[43]
WHO Expert Committee on Drug Dependence, World Health Organization WHO Expert Committee on Drug Dependence [meeting held in Geneva from 9 to 16 April 1987]: twenty-fourth report. World Health Organization, 1988.
[46]
Jacobson, R.A.U.S. Patent 2090594, 1937.
[47]
Greene, R.; Phoenix, T. E.P. Patent 0896532B1, 1999.
[48]
Joppien, Hartmut K.R. Patent 830002202B1, 1983.
[49]
Ruat, M.; Faure, H.; Traiffort, E.U.S. Patent 9073835B2, 2015.
[50]
Michael, F.U.S. Patent 5135953A, 1992.
[51]
Robert, C.U.S. Patent 2850530A, 1956.
[52]
Guckian, K.N. E.P. Patent 2877166B1, 2013.
[53]
Floyd, W.C. E.P. Patent EP0240370A2,
[54]
E.P. Patent, EP0193249A2,,
[55]
Linus, S.U.S. Patent 7576239B2, 2009.
[56]
E.P. Patent 0416250A2,
[57]
U.S. Patent 3933908A, 1976.
[58]
Raymond, Robert W.O. Patent 2001036403A1, 2000.
[59]
Breitfelder, S. D.E. Patent 60036726T2, 2002.
[60]
McSherry, D.D.; Richard, K.U.S. Patent 8017082B2, 2009.
[61]
Woonza, M.U.S. Patent 8197802B2, 2011.
[62]
Ishii, Yasutaka J.P. Patent 4920024B2, 2012.
[63]
Zhao, Xuan.; Michael, D. U.S Patent 20220079936A1, 2022.
[64]
Tanaka, Y J.P. Patent 5638085B2, 2013.
[65]
Kaiser-Wilhelm, A J.P. Patent 6906445B2, 2021.
[66]
Guillen, K.H.U.S. Patent 10905797B2, 2019.
[67]
Tamera, B.U.S. Patent 11541075B2, 2023.
[68]
Shenghong, A.U.S. Patent 20080161554A1, 2008.
[69]
Liu, Quan Lin Baiqiao C.N. Patent 101970097B, 2009.
[70]
V, Esbelin E.P. Patent 2797974B1, 2014.
[71]
Igor, K.U.S. Patent 8101375B2, 2012.
[72]
Sadozai U.S. Patent 6548081B2, 2003.
[73]
BorZilleri U.S. Patent 7989477B2, 2011.
[74]
Fäcke Thomas U.S. Patent 11000976B2, 2021.
[102]
Stubbins, J.F. Synthesis of potential analgesics: N-(2-dialkylaminoethyl) 2-phenylacetanilides; University of Minnesota, 1965.